CEA Antikörper (full length) (CF®488A)
Kurzübersicht für CEA Antikörper (full length) (CF®488A) (ABIN7877823)
Target
Alle CEA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- CEA Antibody / Carcinoembryonic Antigen
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- Human full-length recombinant CEA protein was used as the immunogen for this antibody.
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the CEA antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 500 µL at 0.1 mg/mL with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store the CEA antibody at 2-8oC, protected from light.
-
-
- CEA (Carcinoembryonic Antigen Gene Family (CEA))
-
Andere Bezeichnung
- CEA
-
Hintergrund
- This antibody recognizes proteins of 80-200 kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70 % are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.
-
UniProt
- P06731
Target
-